Skip to main content
. 2022 Jun 23;10(4):e01006-22. doi: 10.1128/spectrum.01006-22

TABLE 1.

Features of the 17 P. aeruginosa strains included in this study

Strain yr of isolation Phenotype Origina STb O type Resistance patternc MIC (mg/L)d
CST NAC
PAO1 1954 Nonmucoid Wound ST549 O5 Wild type 2 64,000
Z33 2005 Nonmucoid CF ST235 O11 CPr, FQr, AGr 1 16,000
Z34 2006 Nonmucoid CF ST17 O1 CBr, CPr, FQr, AGr 2 64,000
Z35 2006 Nonmucoid CF ST235 O11 1 16,000
Z152 2013 Mucoid CF ST155 O6 CBr, FQr, AGr 2 8,000
Z154 2016 Mucoid CF ST412 O6 CPr, FQr, AGr 2 16,000
M1 2002 Mucoid CF ST155 O6 CBr, CPr, FQr, AGr 2 16,000
M4 2005 Mucoid CF ST155 O6 CBr, CPr, FQr, AGr 2 32,000
M7 2005 Mucoid CF ST253 O10 AGr 2 64,000
M13 2000 Mucoid CF ST274 O3 CBr, CPr, AGr 1 32,000
M19 2006 Mucoid CF ST3509 O7 1 64,000
M25 2002 Mucoid CF ST235 O11 2 16,000
M32 2006 Mucoid CF ST235 O11 2 16,000
M42 2007 Mucoid CF ST2437 O6 CBr, CPr, FQr, AGr 2 32,000
FC237 2007 Nonmucoid CF ST365 O3 CBr, FQr, AGr, CSTr 512 64,000
FC238 2007 Nonmucoid CF ST910 O6 CBr, CSTr 8 64,000
FZ99 2018 Nonmucoid RTIICU ST111 O12 CBr, CPr, FQr, AGr, CSTr 4 64,000
a

CF, cystic fibrosis; RTIICU, respiratory tract infection in intensive care unit.

b

According to the MLST Pasteur scheme.

c

CBr, resistance to carbapenems (imipenem and meropenem); CPr, resistance to cephems (ceftazidime and cefepime); FQr, resistance to fluoroquinolones (ciprofloxacin); AGr, resistance to aminoglycosides (amikacin and gentamicin); CSTr, resistance to colistin.

d

CST, colistin; NAC, N-acetylcysteine.